Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival.

Peeter KarihtalaSuvi-Katri LeivonenUlla PuistolaElina UrpilainenAnniina JääskeläinenSirpa LeppäArja Jukkola

Published in: Breast cancer research : BCR (2024)

Inflammation and immunity-related serum proteins have the potential to rise above the classical prognostic factors of early-stage breast cancer. They may also help to distinguish benign from malignant breast lesions.

Keyphrases

prognostic factors
early stage
early breast cancer
oxidative stress
single cell
binding protein
risk assessment
sentinel lymph node
young adults
lymph node
climate change
rectal cancer
childhood cancer